Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia To Consider Removal Of Popular Painkiller From OTC

This article was originally published in PharmAsia News

Executive Summary

Australia authorities are considering a move to remove over-the-counter status for one of the country's favorite painkillers, Nurofen's Nurofen Plus (ibuprofen, codeine phosphate). An advisory panel has set a June meeting to consider the proposal to move Nurofen Plusand similar painkillers containing codeine to prescription-only status. Physician and pharmacy groups say the move is too drastic and suggest an alternative could be limiting the size of packets of the drugs. The nation's leading medical journal reported misuse of such drugs, particularly Nurofen Plus, is a significant problem in the country. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068204

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel